PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
April 3, 2026Mini-Reviews in Medicinal Chemistry

Advances in the Understanding and Mechanisms of Cabergoline-Induced Valvulopathy in Prolactinoma Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

ZTZilong TanTWTengTeng WangWHWei He

Discussion

Loading...

Member takes

Overview

This review examines the mechanisms of valvulopathy in prolactinoma patients treated with cabergoline, suggesting monitoring improvements.

Key Points

  • This review explores the mechanisms underlying cabergoline-induced valvulopathy, particularly in prolactinoma patients.
  • Reviewed existing literature on cabergoline's effects on heart valves
  • Analyzed molecular pathways associated with cabergoline use
  • Discussed inflammatory responses related to valvular disease
  • Identified cabergoline's interaction with catecholaminergic and serotonergic pathways
  • Highlighted concerns over the safety of long-term cabergoline treatment
  • Revealed controversy regarding cabergoline's link to specific heart valve diseases

Cite This Study

Tan et al. (2026) studied this question.

synapsesocial.com/papers/69cf5f105a333a821460dddfhttps://doi.org/10.2174/0113895575419669260114072747
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 15-Hydroxytryptamine 2B receptor regulates cell-cycle progression: Cross-talk with tyrosine kinase pathways2000 · 179 citations
  2. 2Norepinephrine transporter function and human cardiovascular disease2012 · 109 citations
  3. 3Valvular heart disease and the use of cabergoline for the treatment of prolactinoma2008 · 119 citations
  4. 4The Third Case of Cabergoline-Associated Valvulopathy: The Value of Routine Cardiovascular Examination for Screening2018 · 23 citations
  5. 52021 ESC/EACTS Guidelines for the management of valvular heart disease2021 · 5,671 citations